East Lyme, CT, United States of America

Kevin K -c Liu

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin K -c Liu. Retrieved from https://idiyas.com/inventor/kevin-k-c-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kevin K -c Liu: Innovator in Pharmaceutical Chemistry

Introduction

Kevin K -c Liu is a notable inventor based in East Lyme, Connecticut. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the human body. His work is essential in advancing treatments for various diseases.

Latest Patents

Kevin K -c Liu holds a patent for "Cyclopentapyridine and tetrahydroquinoline derivatives." This patent describes 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds of Formula (I), including salts, hydrates, and solvates thereof. These compounds act as 5-HT receptor ligands and have potential uses in treating diseases linked to the activation of 5-HT receptors. He has 1 patent to his name.

Career Highlights

Kevin is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development of innovative therapeutic solutions. His expertise in medicinal chemistry has been instrumental in advancing the company's drug development initiatives.

Collaborations

Kevin has collaborated with notable colleagues, including Bruce A Lefker and Hou Chen. Their combined efforts in research have contributed to the advancement of pharmaceutical sciences.

Conclusion

Kevin K -c Liu is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments. His innovative compounds and collaborations highlight his commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…